Civic AI
Procurement intelligence
Federal contract award
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: SEVERABLE
UNIVERSITY OF CALIFORNIA, DAVIS · Department of Health and Human Services
- Value
- $143,208
- Start
- Aug 1, 2025
- End
- Apr 30, 2026
- Action date
- Jan 30, 2026
- PIID
- 75N94025F00001
- Status
- completed
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- DAVIS, CA
- Award type
- DELIVERY ORDER
Description
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: SEVERABLE
Need modifications, related awards, and vendor peers? Open the full award workspace.